Is Pulse Biosciences' (PLSE) Thyroid Cancer Feasibility Study a Prelude to a Broader Platform Strategy? [Yahoo! Finance]
Pulse Biosciences, Inc (PLSE)
Last pulse biosciences, inc earnings: 11/7 03:42 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.pulsebiosciences.com
Company Research
Source: Yahoo! Finance
Percutaneous Electrode System using nanosecond pulsed field ablation to treat small papillary thyroid microcarcinoma tumors under 1.5 cm at sites in Florida and Texas. This move extends Vybrance's use from benign thyroid nodules into a cancer indication under an Investigational Device Exemption, potentially broadening its clinical and commercial scope if safety and effectiveness are confirmed. We'll now examine how initiating a first-in-human thyroid cancer feasibility study with Vybrance could influence Pulse Biosciences' broader investment narrative. Find 49 companies with promising cash flow potential yet trading below their fair value Pulse Biosciences Investment Narrative Recap To own Pulse Biosciences, you need to believe nanosecond PFA can become a differentiated standard across thyroid and cardiac procedures, eventually justifying today's high valuation despite minimal revenue and sizable losses. The new first in human thyroid cancer study adds clinical depth but doe
Show less
Read more
Impact Snapshot
Event Time:
PLSE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PLSE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PLSE alerts
High impacting Pulse Biosciences, Inc news events
Weekly update
A roundup of the hottest topics
PLSE
News
- Truffle Capital Unveils the First Edition of the Truffle MedTech 10 [Yahoo! Finance]Yahoo! Finance
- Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data [Yahoo! Finance]Yahoo! Finance
- Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical DataBusiness Wire
- A Look At Pulse Biosciences (PLSE) Valuation As Thyroid Cancer Feasibility Study Begins [Yahoo! Finance]Yahoo! Finance
- Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology [Yahoo! Finance]Yahoo! Finance
PLSE
Earnings
- 2/19/26 - Beat
PLSE
Sec Filings
- 3/17/26 - Form 8-K
- 3/12/26 - Form 8-K
- 3/9/26 - Form 8-K
- PLSE's page on the SEC website